Historical record - last NADAC publication: 11/23/2022
Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.5694 per EA under NDC 76282067730. Its NADAC has been published 74 times since Jul 7, 2021.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEStrength
200; 300 mg/1; mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282067730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
11/23/2022
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090958On Market Since
4/6/2021
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has been published 74 times since Jul 7, 2021, and over the history we have for it it has declined 51.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5694 per EA |
|---|---|
| All-time high | $1.5055 (Aug 11, 2021) |
| All-time low | $0.5694 (Nov 23, 2022) |
| Median price | $0.7405 |
| Average price | $0.8360 |
| Largest weekly change | -36.5% (Sep 22, 2021) |
| Weeks tracked | 74 |
| Tracking since | Jul 7, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, manufactured by Exelan Pharmaceuticals Inc., is $0.5694 per EA (NDC 76282067730), effective Nov 30, 2022.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has declined 51.7%. It has been tracked across 74 weekly CMS publications since Jul 7, 2021.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
Since Jul 7, 2021, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has ranged from a low of $0.5694 (Nov 23, 2022) to a high of $1.5055 (Aug 11, 2021), with a median of $0.7405 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, but none are currently priced below it.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB (NDC 76282067730) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification